Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Stopped We need to make significant adjustments to proposed drug and its delivery method

Conditions

• Pancreatic Adenocarcinoma

Interventions

• DRUG: Retrograde venous infusion of gemcitabine/lipiodol

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins